Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Okoye, N. F.
- Invivo Effect of Microgynon and Primolut-n on Plasma Sodium and Potassium of Wistar Albino Rat
Abstract Views :597 |
PDF Views:338
Authors
Affiliations
1 Department of Biochemistry, University of Port Harcourt, Nigeria. P.M.B 5323, Port Harcourt, NG
1 Department of Biochemistry, University of Port Harcourt, Nigeria. P.M.B 5323, Port Harcourt, NG
Source
Indian Journal of Drugs and Diseases, Vol 1, No 4 (2012), Pagination: 92-96Abstract
Microgynon (0.15mg levonorgestrel and 0.03mg ethinylestradiol), is an oral contraceptives Primolut -N a mini pill (5mg norethisterone) were analysed for their in-vivo effects on albino rat plasma sodium and potassium levels. Studies showed that the drugs decreased sodium levels with microgynon showing the highest decrease of 29.85% at highest concentration level of 3.6μg /100g (94.00 ± 28.50mmol/l) (P < 0.05), followed by Primulot-N (102 ± 28.50 mmol/l). Investigations also revealed that the drugs decreased plasma potassium levels. Microgynon had the highest decrease of 88.88% for the highest dose of 3.60μg/100g body wt, while the lowest decrease of 22.22% was observed for the lowest dose of 0.36μg/100g).The sodium element plays an important role in salt and water balance in the body. The metabolism of sodium and potassium is closely linked with the maintenance of fluid balance and with the regulation of acid-base status, Elevated levels are related to acidosis as well as too much water crossing the cell membrane. The potassium element is found primarily inside the cells of the body. The random use of the drugs in our society today especially as most women abuse these drugs demands for more biochemical research to elucidate the effects of these drugs not only on the hormones but also on other biochemical parameters like the body electrolytes. This result indicates that laboratory tests are needed for women before using these drugs.Keywords
Microgynon, Primulot-n, Plasma Sodium and PotassiumReferences
- Bracken MB and Hellenbrand KG and Holford TR (1990) Conception delay after oral contraceptive use: The effect of estrogen dose. Fertil. Steril. 53,21.
- CHPE, Division of Reproductive Health (1984) Family Planning Methods and Practice: Africa. U. S. Public Health service. Department of Health and Human Services, Atlanta Georgia 30333. USA.
- Ghoneim SM, Toppozada RK, El-Heneidy AR and Taha MM (1975) The effects of an oral contraceptive on acid-base balance, blood gases and electrolytes. J. Contraception.12(4),395 -405.
- Grimes DA, Mishell DR, Jr. and Speroff L (1993) Contraceptive choices for women with medical problems. Am. J. Obstet. Gynecol. 198,625-630.
- Henderson M, Dorflinger J, Fishman J, Foster HW, Gump FE, Hellman S, Hulka BS, Mattison DR, McKay SAR, Moses LE, Norsigian J, Potts M, Schwartz NB, Smith H, Stolley PD and Wiggins PV (1991) Oral contraceptives and breast cancer. National academy press. pp: 1-77.
- Henry RJ (1974) Clinical Chemistry, Principles and Technics, 2nd Edn, Harper and Row. pp: 525.
- Kay CR, Crombie DL, Kuenssberg EV, Pinsent RJFH, Richards B, Smith A and Crowther CH (1974) Oral contraceptives and health. The royal college of general practitioners study. Am. J. Obstet. Gynecol. 10,150.
- Kuhl H and Goethe JW (1990) Pharmacokinetics of oral contraceptives, steroids and drug interaction. Am. J. Obst. Gynaecol. 163, 2113.
- Mishell DR Jr (1982) Nonecontraceptive health benefits of oral steroidal contraceptives. Am. J. Obstet. Gynecol. 142, 809.
- Scott JA and Brenner PF (1978) Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituairtary function. Fertil. steril. 30,141.
- Skouby SO and Jesperson J (1990) Oral contraceptives in the nineties, metabolic aspects, facts and fiction. Am. J. Obstet Gynecol. 163,276.
- Smith RP and Sizto R (1983) Metabolic effects of two triphasic formulations containing ethinyl estradiol and dl-norgestrel. J. Contraception. 28 (2),189 -199.
- Terri AE and Sesin PG (1958) Fundamentals of Clinical Chemistry. Am. J. Clin. Path. 29,86.
- Tietz NW (1995) Clinical guide to laboratory tests, 3rd edn. WB Saunders Co. Philadelphia, PA. 874.
- Trinder P (1951) Invitro determination of sodium in serum. Analyst. 76,596.
- Wootton IDP and Freeman H (1982) Microanalysis in medical biochemistry, 6th Edn, Churchill Livingstone Inc. NY, USA. pp: 1-190.
- World Health Organization Task Force on Oral Contraceptives (1982). A randomized, double-blind study of two combined and two progestogen-only oral contraceptives. Contraception. 25,243.
- A Study of the invivo Effect of Microgynon and Primolut-n on Albino Rat Plasma Aspartate Amino Transferase (EC 2.6.1.1) and Alanine Amino Transferase (EC 2.6.1.2) at 37°c, Ph = 9.8
Abstract Views :419 |
PDF Views:315
Authors
Affiliations
1 Department of Biochemistry, University of Port Harcourt, Nigeria. P.M.B 5323, Port Harcourt, NG
1 Department of Biochemistry, University of Port Harcourt, Nigeria. P.M.B 5323, Port Harcourt, NG
Source
Indian Journal of Drugs and Diseases, Vol 1, No 4 (2012), Pagination: 97-102Abstract
Oral contraceptives namely Microgynon a combined pill (0.15mg levonorgestrel and 0.03mg ethinylestradiol) and Primolut -N a mini pill (5mg norethisterone) were analysed for their in-vivo effects on albino rat plasma and erythrocyte aspartate amino transferase (AST). The in-vivo effects of the oral contraceptives on albino rat plasma and erythrocyte AST showed that the drugs inhibited the activity of the enzymes in a concentration dependent manner. The effect of the drugs on the enzymes were also time dependent with the highest inhibition obtained at 24 hours duration while the least inhibition occurred at 2 hours duration Microgynon showed the highest inhibition (7.00 ± 0.00 vs. control 31.00 ± 0.00 U/L) (P < 0.05) followed by Primolut (16.00 ± 0.00 vs. control 27.00 ± 4.00 U/L). The erythrocyte AST activity was also inhibited. The highest inhibition values obtained were Microgynon (36.00 ± 0.00 U/L) then Primolut (41.00 ± 0.00 U/L). The least inhibition values obtained were Microgynon and Primolut (67.00 ± 0.00). The in-vivo effects of the oral contraceptives on rat plasma and erythrocyte ALT showed that the drugs activated the activity of the enzymes in a concentration dependent manner. The effect of the drugs on the enzymes were also time dependent with the highest activation obtained at 24 hours duration while the least activation occurred at 2 hours duration. Primolut showed the highest activation (18.00 ± 0.00 U/L). The erythrocyte enzymes showed higher activity than the plasma enzymes. Microgynon showed the highest activity (50.00 ± 2.00 U/L). This result indicates that liver function tests are needed for women before using these drugs.Keywords
Microgynon, Primolut –NReferences
- Brenner PF, Mishell DR Jr and Stanezyk FZ (1977) Serum levels of D-norgestrel, luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone in women during and following ingestin of combination oral contraceptive containing dl-norgestrel. Am. J. Obstet. Gynecol. 129,133.
- Briggs M (1980) Effects of oral contraceptive agents on vitamin and mineral requirements. J. Am. Diet Assoc. 5, 160.
- CHPE, Division of Reproductive Health (1984) Family planning methods and practice. US public health service. Department of Health and Human Services, Atlanta, Georgia 30333. USA.
- Devlin MT (1992) A textbook of Biochemistry with clinical correlation 3rd ed. John Wiley and sons publication USA.pp: 100.
- Grimes DA, Mishell DR Jr and Speroff L (1993) Contraceptive choices for women with medical problems. Am. J. Obstet. Gynecol. 198, 625-630.
- Hargreaves T (1969) Oral contraceptives and liver function. J. Clin. Pathol. Suppl. 3, 1-10.
- Kaunitz AM (2004) Enhancing oral contraceptive success: the potential of new formulations. Am. J. Obstet. Gynecol. 190 (4), 23-29.
- Kay CR, Crombie DL, Kuenssberg EV, Pinsent RJFH, Richards B, Smith A, Crowther CH (1974) Oral contraceptives and health. The royal college of general practitioners study. Am. J. Obstet. Gynecol. 10,150.
- Kuhl H and Goethe JW (1990) Pharmacokinetics of oral contraceptives, steroids and drug interaction. Am. J. Obstetric & Gynaecol. 163, 2113.
- Mishell DR Jr, Stanezyk FZ and Hiroi M (1976) Steroid contraception. In: Crosignami PC, Mishell DR Jr (eds): Ovulation in the Human. London, Academic press. pp: 10.
- Ohno H, Tojo H, Kajimura T and Nomura M (1994) Increased serum alkaline phosphatase induced by DT-5061, an oral contraceptive, in rats. J. Toxicol. Sci. 19 (3), 507-518.
- Reitman S and Frankel S (1957) In vitro determination of Glutamic-Oxaloacetic Transaminase (GOT) and Glutamic-Pyruvic transaminase (GPT) in serum. Am. J. Clin. Path. 28,56.
- Skouby SO and Jesperson J (1990) Oral contraceptives in the nineties, metabolic aspects, facts and fiction. Am. J. Obstet Gynecol. 163, 276.
- Swyer GIM (1982) Petency of pregestogens in oral contraceptives-further delay of menses data. Contraception. 26,23.
- Sy FS, Osteria TS, Opiniano V and Gler S (1986) Effects of oral contraceptives on liver function tests of women with schistosomiasis in the Philippines. J. Contraception. 34(3), 283 -294.